Health-Care Overhaul and Industry Outlook: Cephalon


Published On: May 5th, 2010

The drug maker expects Medicaid drug discounts to add between $7 million and $11 million in expenses this year and next, with additional reform-related expenses in 2011.

Here is the original post:
Health-Care Overhaul and Industry Outlook: Cephalon



Loading...


Comments are closed.